Empire Financial Management Company, LLC Gilead Sciences, Inc. Transaction History
Empire Financial Management Company, LLC
- $302 Billion
- Q2 2024
A detailed history of Empire Financial Management Company, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Empire Financial Management Company, LLC holds 3,200 shares of GILD stock, worth $252,064. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,200
Previous 3,200
-0.0%
Holding current value
$252,064
Previous $234 Million
6.33%
% of portfolio
0.07%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
1,879Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$9.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.08 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.01 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$4.76 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.67 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $98.7B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...